Study on the mechanisms responsible for the development and growth of dural arteriovenous fistula

硬脑膜动静脉瘘发生和生长的机制研究

基本信息

  • 批准号:
    14370444
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

Although various mechanisms of the development of dural arteriovenous fistula(DAVF) have been proposed, the pathogenesis of these lesions are still unclear. Recent experimental evidence suggested a role of angiogenic growth factors in the genesis of vascular malformations of the central nervous system. To further investigate the pathogenesis of DAVF, we examined the expression of the angiogenic growth factor, vascular endothelial growth factor(VEGF), in rat DAVF model.<Experiment-1> Male Wistar rats were used. DAVF model (Spetzler) was made, and venous hypertension was induced which were divided into two experimental groups ; immunohistological study group and angiography group. Immunohistological analysis was performed by VEGF antibody 1 week after, and angiography was done 90 days after the surgery. As a result, VEGF expression in the endothelium and the connective tissues of the dura matter in the five rats (33%) and in the neurons in the eleven rats (73%) of the cerebral cortex and the basal ganglia were identified. DAVF formed in 6 among 15 rats (40%). <Experiment-2> Western blot was performed with different periods from 1, 2 and 3 weeks after inducing venous hypertension in the same model. The expression of VEGF was peaked at one week after venous hypertension, and decreased by the order of two and three weeks (1>2>3 week). The expression of immunoreactive VEGF was restricted in the connective tissue and the endothelial layer of the dura matter, cerebral cortical tissue and basal ganglia neurons.In conclusions, these results strongly suggest a possible contribution of the VEGF system to the growth of DAVF. Venous ischemia by venous hypertension might be responsible for inducing up-regulation of angiogenic factor expression.
虽然硬脑膜动静脉瘘(DAVF)的发生机制多种多样,但其发病机制仍不清楚。最近的实验证据表明,血管生成生长因子在中枢神经系统血管畸形的发生中的作用。为了进一步研究DAVF的发病机制,我们检测了大鼠DAVF模型中血管生成生长因子血管内皮生长因子(VEGF)的表达。<Experiment-1>使用雄性Wistar大鼠。制作DAVF模型(Spetzler法),建立静脉高压模型,分为两个实验组:免疫组化组和血管造影组。术后1周行VEGF抗体免疫组化染色,术后90天行血管造影。结果,在5只大鼠(33%)的硬脑膜的内皮和结缔组织中以及在11只大鼠(73%)的大脑皮层和基底神经节的神经元中鉴定出VEGF表达。15只大鼠中有6只(40%)形成DAVF。<Experiment-2>在同一动物模型上,分别于诱导静脉高压后1、2、3周进行Western blot检测。VEGF表达在静脉高压后1周达高峰,2、3周依次下降(1&gt;2&gt;3周)。免疫反应阳性的VEGF表达仅限于硬脑膜的结缔组织和内皮层、大脑皮质组织和基底节神经元。静脉高压引起的静脉缺血可能是导致血管生成因子表达上调的原因。

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
最新脳神経外科手術(三宅悦夫編集)
最新神经外科手术(三宅悦雄主编)
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    榊 寿右
  • 通讯作者:
    榊 寿右
Kaido T.: "Brain metastases from urachal carcinoma."J Clin Neuroscience. 10・6. 703-705 (2003)
Kaido T.:“脐尿管癌的脑转移。”J Clin Neuroscience 10・6(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Nakase: "A scanning technique to measure regional cerebral blood flow and oxyhemoglobin level"Neurosurgery. 48・6. 1335-1342 (2001)
H.Nakase:“测量局部脑血流量和氧合血红蛋白水平的扫描技术” 48・6(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Nakase: "Clinical study on recurrent intracranial aneurysms."Cereb Vas Dis. 10. 255-260 (2000)
H.Nakase:“复发性颅内动脉瘤的临床研究。”Cereb Vas Dis。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chemical preconditioning prevents paradoxical increase in glutamate release during ischemia by activating ATP-dependent potassium channels in gerbil hippocampus.
化学预处理通过激活沙鼠海马中 ATP 依赖性钾通道来防止缺血期间谷氨酸释放的反常增加。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKAKI Toshisuke其他文献

SAKAKI Toshisuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKAKI Toshisuke', 18)}}的其他基金

Study on the treatment of dural arteriovenous fistula by the inhibition of angiogenic growth factors
抑制血管生成因子治疗硬脑膜动静脉瘘的研究
  • 批准号:
    18390402
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Hemodynamics of chronic venous hypertension in rat
大鼠慢性静脉高压的血流动力学
  • 批准号:
    11470296
  • 财政年份:
    1999
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Pathological Process of Cerebral Venous Circulation Disturbance
脑静脉循环障碍的病理过程研究
  • 批准号:
    07457321
  • 财政年份:
    1995
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Cerebral Blood Flow, Cerebral Metabolism and Pathological Changes in Cerebral Venous Occlusion
脑静脉阻塞时脑血流、脑代谢及病理变化的研究
  • 批准号:
    05454401
  • 财政年份:
    1993
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Novel Long-Acting Inhibitors of Vascular Endothelial Growth Factor (VEGF) for Treatment of Intraocular Vascular Disorders
用于治疗眼内血管疾病的新型长效血管内皮生长因子 (VEGF) 抑制剂
  • 批准号:
    10374056
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Novel Long-Acting Inhibitors of Vascular Endothelial Growth Factor (VEGF) for Treatment of Intraocular Vascular Disorders
用于治疗眼内血管疾病的新型长效血管内皮生长因子 (VEGF) 抑制剂
  • 批准号:
    10610820
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Bioresponsive theranostics for activity on demand delivery of Vascular Endothelial Growth Factor (VEGF)
用于按需输送血管内皮生长因子 (VEGF) 的生物反应性治疗诊断学
  • 批准号:
    399329442
  • 财政年份:
    2018
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grants
Effect of Vascular Endothelial Growth Factor (VEGF) on physiological polymorphism of bone metabolism
血管内皮生长因子(VEGF)对骨代谢生理多态性的影响
  • 批准号:
    17K07593
  • 财政年份:
    2017
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of the renal epithelial sodium channel (ENaC) by the vascular endothelial growth factor (VEGF) and the pathogenetic role of renal ENaC for VEGF receptor inhibitor-induced hypertension.
血管内皮生长因子 (VEGF) 对肾上皮钠通道 (ENaC) 的调节以及肾 ENaC 对 VEGF 受体抑制剂诱导的高血压的发病作用。
  • 批准号:
    288511211
  • 财政年份:
    2016
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grants
Metabolic remodeling of glioblastoma by vascular endothelial growth factor (VEGF) inhibitor Bevacizumab
血管内皮生长因子(VEGF)抑制剂贝伐珠单抗对胶质母细胞瘤的代谢重塑
  • 批准号:
    16K20010
  • 财政年份:
    2016
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Neuropilin-1 as mediator for Vascular Endothelial Growth Factor (VEGF)-dependent T cell migration
Neuropilin-1 作为血管内皮生长因子 (VEGF) 依赖性 T 细胞迁移的介质
  • 批准号:
    237773923
  • 财政年份:
    2013
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grants
The paracrine and autocrine roles of Vascular Endothelial Growth Factor (VEGF) in ischemic skeletal muscle and endothelial cells.
血管内皮生长因子(VEGF)在缺血骨骼肌和内皮细胞中的旁分泌和自分泌作用。
  • 批准号:
    443807-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Pathogenesis of intervertebral disc degeneration and functional analysis of vascular endothelial growth factor (VEGF) in the intervertebral disc
椎间盘退变的发病机制及椎间盘血管内皮生长因子(VEGF)的功能分析
  • 批准号:
    24791570
  • 财政年份:
    2012
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Clinical study of anti-vascular endothelial growth factor(VEGF) therapy
抗血管内皮生长因子(VEGF)治疗的临床研究
  • 批准号:
    23591608
  • 财政年份:
    2011
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了